RNA STOCK ALERT: HALPER SADEH LLC IS INVESTIGATING WHETHER THE SALE OF AVIDITY BIOSCIENCES, INC. IS FAIR TO SHAREHOLDERS

Core Viewpoint - Halper Sadeh LLC is investigating the fairness of the proposed sale of Avidity Biosciences, Inc. to Novartis for $72.00 per share in cash, focusing on the rights and interests of Avidity shareholders [1][2]. Group 1: Investigation Details - The investigation examines whether Avidity and its board violated federal securities laws and fiduciary duties by not securing the best possible consideration for shareholders [2]. - Concerns include whether Novartis is underpaying for Avidity and if all material information necessary for shareholders to assess the merger was disclosed [2]. Group 2: Potential Actions - Halper Sadeh LLC may seek increased consideration for Avidity shareholders, additional disclosures, and other forms of relief related to the transaction [3].